← Back to Search

UV Microscopy for Cervical Cancer Screening

N/A
Waitlist Available
Led By Steven J Dudick, MD
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients presenting for follow-up for positive cervical cancer screening.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at how UV microscopy can detect cervical precancer & cancer, to help diagnose & prevent it.

Who is the study for?
This trial is for individuals undergoing cervical cancer screening or follow-up after a positive screening. It's designed to test if ultraviolet microscopy can effectively identify early changes in cervical cells that could lead to cancer.
What is being tested?
The study is testing the use of ultraviolet microscopic analysis as a tool for cervical cancer screening. It will compare the images from this new method with results from traditional liquid-based Pap tests to see how well it identifies cell changes.
What are the potential side effects?
Since this trial involves non-invasive imaging with ultraviolet microscopy, there are no direct side effects associated with the procedure itself, unlike drug treatments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am following up on a positive cervical cancer screening result.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Cellular features

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Enrolled PatientsExperimental Treatment1 Intervention
Consented patients who have had an additional Pap sample taken at their visit.

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor
536 Previous Clinical Trials
159,708 Total Patients Enrolled
Steven J Dudick, MDPrincipal InvestigatorUniversity of Arizona
~121 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top